BNTC insider buying
3 cluster buysBenitec Biopharma Inc. · Healthcare
When two or more insiders at Benitec Biopharma Inc. buy BNTC on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in BNTC plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Dec 19 – Dec 29, 2025Detected Dec 29, 20252 insidersTotal bought$2.1MMarket cap$436.0M
- Mar 26 – Mar 31, 2025Detected Mar 31, 20252 insidersTotal bought$11.8MMarket cap$436.0M
- Nov 19 – Dec 3, 2024Detected Dec 3, 20242 insidersTotal bought$726.9KMarket cap$436.0M
All notable open-market buys in BNTC
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Dec 29, 2025 | Cowen Aaroncluster Director, 10% Owner | 65,800 | $13.44 | $884.4K | SEC ↗ |
| Dec 29, 2025 | Cowen Aaroncluster Director, 10% Owner | 11,587 | $13.44 | $155.7K | SEC ↗ |
| Dec 26, 2025 | Cowen Aaroncluster Director, 10% Owner | 14,320 | $13.10 | $187.6K | SEC ↗ |
| Dec 23, 2025 | Cowen Aaroncluster Director, 10% Owner | 42,600 | $12.85 | $547.4K | SEC ↗ |
| Dec 22, 2025 | 10% Owner | 16,650 | $12.08 | $201.1K | SEC ↗ |
| Dec 19, 2025 | 10% Owner | 13,950 | $11.48 | $160.1K | SEC ↗ |
| Nov 7, 2025 | Director, 10% Owner | 751,111 | $13.50 | $10.1M | SEC ↗ |
| Nov 7, 2025 | Director, 10% Owner | 730,370 | $13.50 | $9.9M | SEC ↗ |
| Mar 31, 2025 | Director, 10% Owner | 9,503 | $12.63 | $120.0K | SEC ↗ |
| Mar 26, 2025 | Cowen Aaroncluster 10% Owner | 793,800 | $13.00 | $10.3M | SEC ↗ |
| Mar 26, 2025 | Cowen Aaroncluster 10% Owner | 106,200 | $13.00 | $1.4M | SEC ↗ |
| Dec 24, 2024 | 10% Owner | 17,730 | $11.25 | $199.5K | SEC ↗ |
| Dec 23, 2024 | 10% Owner | 24,360 | $10.98 | $267.5K | SEC ↗ |
| Dec 3, 2024 | Director, 10% Owner | 37,190 | $9.60 | $357.0K | SEC ↗ |
| Nov 20, 2024 | Averill Master Fund, Ltd.cluster Director, 10% Owner | 24,360 | $10.22 | $249.0K | SEC ↗ |
| Nov 19, 2024 | Averill Master Fund, Ltd.cluster Director, 10% Owner | 12,430 | $9.73 | $120.9K | SEC ↗ |
More Healthcare stocks with insider cluster buys
BNTC insider buying — FAQ
- Are insiders buying BNTC stock?
- Yes — 4 distinct insiders have bought BNTC (Benitec Biopharma Inc.) on the open market, including 3 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Dec 29, 2025.
- How much BNTC stock have insiders bought?
- Insiders have bought a combined $35.2M of BNTC across 16 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in BNTC?
- A cluster buy is two or more distinct Benitec Biopharma Inc. insiders — officers, directors, or 10% owners — each buying BNTC on the open market within a rolling window. BNTC has 3 detected cluster buys to date.
- Where does this BNTC insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in BNTC
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy BNTC within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding BNTC.